 |
인쇄하기
취소
|
Government OKs sale of Novartis-produced MF59-adjuvanted flu vaccine
Korea’s health authorities gave the green light to Novartis Korea to sell MF59-adjuvanted influenza vaccine for elderly people aged 65 or more.
An adjuvant is an agent that enhances the immune system's response to a vaccine by 2 to 4 times.
Novartis Korea said it has begun local sales of the product from September 28 through SK Chemicals and Boryung Pharm.
Vaccination with the MF59-adj...
An adjuvant is an agent that enhances the immune system's response to a vaccine by 2 to 4 times.
Novartis Korea said it has begun local sales of the product from September 28 through SK Chemicals and Boryung Pharm.
Vaccination with the MF59-adj...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.